Another approach to fight breast cancer is using redirected expanding NK-92 cells against the tumor-associated ErbB2 (HER2), a tissue antigen over-expressed in several human tumors, including breast, ovarian, stomach and prostate cancer [154]. Here, ERBB2 is linked to prostate carcinoma.